Notes to Reader[edit | edit source]
Literature review in progress
Background[edit | edit source]
Search Strategy & Terms[edit | edit source]
Key words terms (KWT)
- Open Source Insulin
Strategies
- Searched GoogleScholar using KWT1
What is Open Insulin?[edit | edit source]
The "What" of the topic.
Theoretical Framework[edit | edit source]
The "How" of the topic.
Significance and Importance[edit | edit source]
The "Why" of the topic.
Current State of the Art[edit | edit source]
The "When" of the topic. Review current state with an emphasis on the development of the field over time.
Relevant Stakeholders[edit | edit source]
The "Who" of the topic.
Applicability and Context[edit | edit source]
The "Where" of the Topic
Terms[edit | edit source]
AID= Automated insulin delivery
CGM= Continuous glucose monitoring
Literature[edit | edit source]
TODO[edit | edit source]
- Insulin Patents
- Solid OS bioreactors.
Open Source Insulin[edit | edit source]
Open-source automated insulin delivery: international consensus statement and practical guidance for health-care professionals[edit | edit source]
Braune, K., Lal, R. A., Petruželková, L., Scheiner, G., Winterdijk, P., Schmidt, S., ... & Hussain, S. (2022). Open-source automated insulin delivery: international consensus statement and practical guidance for health-care professionals. The Lancet Diabetes & Endocrinology, 10(1), 58-74.
- Summarizes current evidence and describes relevant technologies for AID
- Highlights global healthcare consensus and provides clinical guidance on adopting open-source systems in medical settings.
- Offers key recommendations for stakeholders in diabetes technology but mostly focuses on Open Source AID algorithms rather than Open Source Insulin Production
The Open Insulin Project: A Case Study for ‘Biohacked’ Medicines[edit | edit source]
Gallegos, J. E., Boyer, C., Pauwels, E., Kaplan, W. A., & Peccoud, J. (2018). The Open Insulin Project: A case study for ‘biohacked’ medicines. Trends in biotechnology, 36(12), 1211-1218.
- The Open Insulin Project is developing a protocol for insulin production to bypass intellectual property restrictions.
Bibliography[edit | edit source]
- Braune, K., Lal, R. A., Petruželková, L., Scheiner, G., Winterdijk, P., Schmidt, S., ... & Hussain, S. (2022). Open-source automated insulin delivery: international consensus statement and practical guidance for health-care professionals. The Lancet Diabetes & Endocrinology, 10(1), 58-74.
- Gallegos, J. E., Boyer, C., Pauwels, E., Kaplan, W. A., & Peccoud, J. (2018). The Open Insulin Project: A case study for ‘biohacked’ medicines. Trends in biotechnology, 36(12), 1211-1218.
